Efficacy and Safety of Baricitinib Versus Azathioprine in Combination With Topical Corticosteroids For Patients With Moderate-to-Severe Atopic Dermatitis
Latest Information Update: 13 May 2025
At a glance
- Drugs Baricitinib (Primary) ; Fluocinolone acetonide (Primary) ; Urea (Primary) ; Azathioprine
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Acronyms BAAZ-AD-IR
Most Recent Events
- 06 May 2025 Status changed from recruiting to active, no longer recruiting.
- 17 May 2024 Planned End Date changed from 15 Aug 2024 to 30 Jun 2025.
- 17 May 2024 Planned primary completion date changed from 15 Aug 2024 to 30 Jun 2025.